Johnson & Johnson buy matumba
Summary
This prediction ended on 12.02.13 with a price of €56.33. With a performance of 2.31%, the BUY prediction by matumba for Johnson & Johnson closed with a slight gain. matumba has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Johnson & Johnson | 0.769% | 0.769% | -2.276% | 5.063% |
iShares Core DAX® | 2.275% | 4.627% | 18.839% | 16.367% |
iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% | 35.232% |
iShares Nikkei 225® | 4.456% | 3.598% | 12.437% | -0.660% |
iShares S&P 500 | 4.061% | 2.876% | 23.447% | 38.511% |
Comments by matumba for this prediction
In the thread Johnson & Johnson diskutieren
Gute Aufträge
Gute Aufträge und gute analystenkommentare
Auch für kurzfristige
Stopped prediction by matumba for Johnson & Johnson
Johnson & Johnson
01.11.19
04.11.21
05.11.21
Johnson & Johnson
22.02.14
04.07.14
04.07.14
Johnson & Johnson
07.04.12
05.07.12
05.07.12